tirzepatide suicidal ideation Once-weekly subcutaneous was not associated with an increased risk of depression compared with placebo, according to a post hoc analysis of the SURMOUNT clinical trial programme. The findings were published in Australia's TGA Updates Safety Warnings

However, such anecdotal reports need to be viewed with caution, as many factors (like lifestyle changes while losing weight) could influence mood

Take the Next Step If youve worked hard to lose weight but are still bothered by sagging skin, you deserve to enjoy the full results of your transformation

A successful self-funded weight management program has to balance cost and care to ensure members receive the right medication at the right price, while also driving sustainable health outcomes

Age, menopause status, underlying thyroid function, and even your baseline cortisol levels can amplify sweating responses

This review seeks to resolve the apparent contradictions in the literature and propose future research directions centered on appropriate patient populations and therapeutic windows